Fitbit's new enterprise offering "Ready for Work" uses symptom checker app and vital signs data to recommend whether an employee can work

June 17, 2020
Digital Transformation More...
by Danielle Bradnan
Very important

The vital signs monitoring is of particular interest because early evidence suggests that heart rate variability and sleep may indicate an oncoming immune response due to a viral pathogen. However, the research to determine the link between vital signs and COVID-19 has only been going on since March (Fibit's study began in May). Any digital biomarkers used to make recommendations either are from an earlier study based on the flu or are extremely preliminary data, without the scientific review necessary to make recommendations yet. Clients should monitor this development with interest because it represents the first commercialized digital biomarker offering for consumers, but be aware that it is based on early-stage research.

For the original news article, click here .

Further Reading

Recovering COVID-19 patients may face higher risk of developing blood clots

News Commentary | April 14, 2021

Scientists at Singapore's Nanyang Technological University reported that recovering COVID‑19 patients with preexisting cardiovascular conditions may be at a higher risk of developing blood clots. The findings come at a time when vaccines from AstraZeneca and Johnson & Johnson have reported rare ... Not part of subscription

InteliCare receives $70,000 grant to build machine learning-based health prediction software for the elderly

News Commentary | June 10, 2021

In partnership with Macquarie University and the University of Sydney, InteliCare is aiming to create a product that can predict healthcare outcomes around elderly patients. The idea behind the system is to be able to predict aging concerns like chronic disease, falls, and dementia in time to alert ... Not part of subscription

Comprehensive genomic screening for pediatric cancer patients unlocks the potential of precision medicine

News Commentary | July 26, 2021

Genomic studies on cancer patients often focus on specific tissues and miss out on clues that might be contained elsewhere as a result. A team from St. Jude's hospital took a comprehensive approach that examined both tumor and germline genomes (the individual's genome that gets passed down to ... Not part of subscription